AWS for Industries
Author: Patrick Buckner
Patrick has over 20 years of experience in the Life Science industry working with biopharmaceutical and medical device companies across North and South America, Europe and Asia via software organizations and 9+ years with the engineering and consulting subsidiary of Novo Nordisk. Patrick has worked across the value chain including R&D, clinical development, manufacturing and supply chain and has led sales and marketing teams in North America and Europe. Currently, he is the WW Business Development Manager, leading the Life Science industry solution program. Patrick received his B.A. from the University of North Carolina-Chapel Hill and a Machine Learning Professional Certification from the Massachusetts Institute of Technology (MIT).
Building a COVID-19 Vaccine Verification Solution on AWS
Buying a COVID-19 vaccination on the dark web for upwards of $1000 only for it never to materialize sounds like something from a Hollywood script. But according to cybersecurity agencies like Check Point, this situation is presenting itself to patients eager for vaccinations. Fraudulent activities like this and fake drug products such as those described […]
Setting the “Industry 4.0” foundations for life sciences manufacturing
Introduction This blog summarizes challenges in life sciences manufacturing along with examples of Amazon Web Services (AWS) customers using cloud technology to improve their operations. We explore reference architectures illustrating how AWS services can be used to establish the foundation for “Industry 4.0.” Finally, we describe an AWS assessment engagement customers can use to understand […]
Conducting end-to-end pharmacovigilance workflows using AWS technologies
Introduction Bio-pharmaceutical companies have always had a responsibility to report adverse events (AE), whether in clinical development or post market-approval scenarios, to the Food and Drug Administration (FDA). The COVID-19 pandemic and the race to find effective treatments for this disease has caused both the FDA and bio-pharmaceutical organizations around the world to re-imagine the […]